In addition, we evaluated NEAT1 expression also in other types of hematological tumors, including B-cell acute lymphoid leukemia (ALL), acute and chronic myeloid leukemia (AML and CML), MM, B cell-lymphoma cell lines, and different types of normal B-cell populations, i.e., 27 samples including normal peripheral blood B-cells (pBC) and naïve and memory B cells purified from spleen or tonsils as specified elsewhere [14]. The gene discussed is NEAT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.